Abivax SA American Depositary Shares (ABVX NASDAQ) stock market data APIs
$132.3396
-1.16(-0.9%)
as of May 29, 2026
Try our APIs with
free plan!
Abivax SA American Depositary Shares Financial Data Overview
Price chart is built with
Anychart
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Prev. Close
132.3396
Open
131.1768
High
133.0495
Low
127.1235
52 wk Range
5.69-148.83
Market Cap
10 570 M
Shares Outstanding
79 695 K
Revenue
4 920 K
EPS
-0.7076
Beta
-0.188
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Abivax SA American Depositary Shares (top by weight)
Ticker
100-day Price Change
Weight
W311.XETRA
HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Accumulating
-0.19
(-2.75%)
4.87
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Abivax SA American Depositary Shares data using free add-ons & libraries
Get Abivax SA American Depositary Shares Fundamental Data
Abivax SA American Depositary Shares Fundamental data includes:
- Net Revenue: 4 920 K
- EBITDA: -254 004 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Abivax SA American Depositary Shares Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-25
- EPS/Forecast: -0.8115
Get Abivax SA American Depositary Shares End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Abivax SA American Depositary Shares News
New
ABIVAX Records Q1 Loss Of EUR 52 Mln; Plans NDA Submission For Obefazimod In Q4
(RTTNews) - ABIVAX Societe Anonyme (ABVX), a clinical-stage biotechnology company, on Saturday reported its first quarter financial results, marking a higher loss due to increased spending on the deve...
Abivax reports Q1 results
* Abivax press release [https://seekingalpha.com/pr/20526408-abivax-presents-first-quarter-2026-financial-results-and-reports-three-year-interim-data-from] (ABVX [https://seekingalpha.com/symbol/ABVX...
Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares
On May 15, 2026, Saturn V Capital Management LP disclosed in an SEC filing that it sold 822,007 shares of Dyne Therapeutics(NASDAQ:DYN), an estimated $14.17 million transaction based on quarterly aver...
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
Key Points Saturn V sold 1,504,880 shares of Ocular Therapeutix in the first quarter; the estimated transaction value was $14.34 million. Meanwhile, the quarter-end position value declined by $18.27 ...
Get Abivax SA American Depositary Shares fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
